Multiple Biomarker Approach to Risk Stratification in COVID-19

Circulation. 2021 Mar 30;143(13):1338-1340. doi: 10.1161/CIRCULATIONAHA.120.053311. Epub 2021 Feb 15.

Authors

Affiliations

¹ Leon H. Charney Division of Cardiology, Department of Medicine (N.R.S., J.S.N., Y.X., H.R.R., J.S.H., G.I.F., J.S.B.), School of Medicine, New York University.
² Department of Medicine, VA New York Harbor Healthcare System (N.R.S.).
³ Department of Population Health, New York University Langone Health, New York (V.N., Y.A.).
⁴ Department of Surgery (J.S.B.), School of Medicine, New York University.

No abstract available

Keywords: C-reactive protein; COVID-19; biomarkers; fibrin fragment D; inflammation; troponin.

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Biomarkers / blood*
C-Reactive Protein / analysis
COVID-19 / mortality
COVID-19 / pathology*
COVID-19 / virology
Comorbidity
Fibrin Fibrinogen Degradation Products / analysis
Hospital Mortality
Hospitalization
Humans
Odds Ratio
Retrospective Studies
Risk Assessment
SARS-CoV-2 / isolation & purification
Troponin I / blood

Substances

Biomarkers
Fibrin Fibrinogen Degradation Products
Troponin I
fibrin fragment D
C-Reactive Protein

Grants and funding